Solutions / Insurance Solutions
Insurance Built for the Peptide Channel, Not Adapted to It.
A proprietary program engineered around how peptide practices actually operate, and around the modalities standard carriers routinely deny.
This proprietary program was conceived with singular focus: to serve peptide distributors, wholesalers, and medical practices that retail peptides labeled for professional use only and counsel patients on their use. Coverage is placed through World Insurance Network, a licensed insurance producer. Availability, eligibility, terms, limitations, and exclusions are determined by underwriting.
Will my malpractice policy cover peptide therapy?
Often it will not. Advanced modalities are frequently excluded or denied outright by standard carriers, and most clinicians discover this only when a claim is filed against them.
The pathway to professional-use peptides is deliberately narrow, and general-market policies were not written with that pathway in mind. Reading your existing policy against the modalities you actually offer is the first step, and it is worth doing whether or not you work with us.
What happens if you're not covered
Nobody in this space is asking clinicians to read their policy. The conversation is about revenue, protocols, and supply. It is never about what your carrier will actually respond to when a complaint arrives.
That silence is the exposure.
An exclusion does not announce itself. It sits in the schedule until a claim is filed, and then it decides who pays. If peptide therapy is excluded from your current policy, the defense, the settlement, and every hour you spend on it are yours.
You have already invested in the education of your staff and physicians, the securing of supply, and the marketing of your practice. The question is whether any of it is protected.
Built around the channel, not adapted to it
The pathway to professional-use peptides is deliberately narrow. Eligibility runs through medical practices operating under a medical director with an NPI number, sourcing from reputable manufacturers and distributors rather than the open market.
This program was engineered around that very channel and insures it as it truly operates. The products liability form carries no peptide type exclusions, which affords settlement and defense cost transfer across the entirety of your peptide portfolio rather than a fragmented arrangement of covered and uncovered products.
That sourcing discipline is not incidental to the coverage. It is what makes the channel assessable, and it is why the program sits alongside Pharmaceutical Supply and Compliance Solutions rather than as a separate purchase.
What's included
- Malpractice coverage access for peptide protocols
- Product liability coverage across the entirety of your peptide portfolio, with no peptide type exclusions in the products liability form
- Professional liability coverage extending into the consultative dimension of your practice, covering advisory services and the guidance you deliver on peptide protocols and treatment plans
- Telehealth practice coverage
How it works
- Review your current coverage against the modalities you actually offer
- Confirm eligibility, crafted for any medical enterprise operating under a medical director with an NPI number
- Structure coverage to complement, not replace, your existing malpractice policy
- Maintain eligibility through the program's training, documentation, and recordkeeping standards
Who places the coverage
Coverage is arranged through World Insurance Network, a licensed insurance producer firm.
Helios Consultants is not an insurance producer and does not sell, solicit, or negotiate insurance. Our role is the documentation, training, and recordkeeping standards that make these modalities assessable to an underwriter.
Introductions to the producer are made through a Helios consultation, where your existing coverage and modalities are reviewed first.
The natural counterpart to the rest of the program
Carriers exclude what they cannot assess. Peptide therapy is not denied because it is uninsurable. It is denied because most practices cannot show an underwriter a documented supply chain, a training record, and consistent charting.
This program stands as the natural counterpart to the Helios philosophy of peptide protocol education, practice build-out revenue models, and access to supply. Each pillar produces the evidence the next one depends on, and coverage is where that evidence pays out.
Frequently asked questions
Advanced modalities without established documentation standards are difficult to underwrite. Carriers exclude what they cannot assess. A documented supply chain and consistent recordkeeping change that assessment.
No. It is structured to complement your existing medical malpractice coverage for qualifying products supplied through the documented ecosystem.
The products liability form carries no peptide type exclusions, so coverage applies across the entirety of your peptide portfolio rather than splitting it into covered and uncovered products. Ask the producer for the form and the current schedule, and read both before you bind.
Yes. The professional liability component extends into the consultative dimension of your practice, covering advisory services and the guidance you deliver on peptide protocols and treatment plans.
The program is crafted for any medical enterprise operating under a medical director with an NPI number, and eligibility is tied to program participation, sourcing through reputable manufacturers and distributors, and adherence to the documentation, training, and recordkeeping requirements. Availability, terms, limitations, and exclusions are subject to underwriting.
Ask your carrier or broker for the current schedule of exclusions and read it against the modalities you actually offer. The coverage review that begins every Helios consultation does exactly this, and it is worth doing whether or not you work with us.
Coverage is placed through World Insurance Network, a licensed insurance producer firm. Helios Consultants is not an insurance producer and does not sell, solicit, or negotiate insurance.
Through a Helios consultation, where your current coverage, modalities, and states are reviewed before an introduction to the producer. Quotes, terms, and binding are handled by the producer, not by Helios.
ImportantInsurance availability, eligibility, and coverage are subject to underwriting, applicable policy terms, limitations, and exclusions. Program materials do not constitute legal, medical, insurance, or regulatory advice. Clinics should consult their own qualified professional advisers.
An investment of that magnitude warrants protection of equal caliber.
You have already committed the education of your staff and physicians, the securing of supply, the marketing of your practice, and the disciplined application of Helios revenue generation principles. What stands behind it is not merely capital, but the far rarer currency of time. Start with a coverage review.